Prostaglandins and chronic inflammation

Trends in Pharmacological Sciences

Volumn 33, Issue 6, 2012, Pages 304-311

  Aoki, Tomohiro ^a   Narumiya, Shuh ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; STROMAL CELL DERIVED FACTOR 1;

ADAPTIVE IMMUNITY; ADENOMATOUS POLYP; ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL EXPANSION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; FIBROSIS; GENE EXPRESSION; GRANULATION TISSUE; HEMODYNAMIC STRESS; HUMAN; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATORY CELL; INNATE IMMUNITY; INTRACRANIAL ANEURYSM; NONHUMAN; PATHOGENESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TISSUE INJURY; TISSUE METAPLASIA; TISSUE REMODELING;

ACUTE DISEASE; ADAPTIVE IMMUNITY; ANIMALS; CELL COMMUNICATION; CHEMOKINES; CHRONIC DISEASE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEEDBACK, PHYSIOLOGICAL; FIBROSIS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LYMPHOCYTES; MACROPHAGES; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDINS; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 84861875788     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.02.004     Document Type: Review

References (68)

1. Ben-Neriah, Y. and Karin, M. (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715-723
2. Donath, M.Y. and Shoelson, S.E. (2011) Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107
3. Rader, D.J. and Daugherty, A. (2008) Translating molecular discoveries into new therapies for atherosclerosis. Nature 451, 904-913 (Pubitemid 351301745)
4. Hirata, T. and Narumiya, S. (2011) Prostanoid receptors. Chem. Rev. 111, 6209-6230
5. Narumiya, S. (2009) Prostanoids and inflammation: a new concept arising from receptor knockout mice. J. Mol. Med. (Berl.) 87, 1015-1022
6. Narumiya, S. and Furuyashiki, T. (2011) Fever, inflammation, pain and beyond: prostanoid receptor research during these 25 years. FASEB J. 25, 813-818
7. 2-EP2/EP4 signaling both mediate joint inflammation in mouse collageninduced arthritis. J. Exp. Med. 203, 325-335
8. Chen, M. et al. (2008) Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. Arthritis Rheum. 58, 1354-1365 (Pubitemid 351705925)
9. Oshima, H. et al. (2011) Prostaglandin E signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 140, 596-607
10. 2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15, 633-640
11. Miossec, P. et al. (2009) Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361, 888-898
12. Fujino, S. et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (Pubitemid 36020767)
13. Lock, C. et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508 (Pubitemid 34546753)
14. Moldovan, I.R. et al. (2003) Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression. J. Neuroimmunol. 141, 132-140 (Pubitemid 37289006)
15. Tzartos, J.S. et al. (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146-155 (Pubitemid 351186376)
16. Bouma, G. and Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533 (Pubitemid 37328672)
17. Korn, T. et al. (2009) IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517
18. Steinman, L. (2008) A rush to judgment on Th17. J. Exp. Med. 205, 1517-1522
19. Harris, S.G. et al. (2002) Prostaglandins as modulators of immunity. Trends Immunol. 23, 144-150 (Pubitemid 34178297)
20. Betz, M. and Fox, B.S. (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113
21. 2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br. J. Pharmacol. 160, 292-310
22. 2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535-548
23. +T cells. Eur. J. Immunol. 39, 1301-1312
24. 2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112, 3696-3703
25. 2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18, 1318-1320
26. 2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 181, 721-735
27. Nakajima, S. et al. (2010) Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J. Immunol. 184, 5595-5603
28. Takahashi, Y. et al. (2002) Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137, 315-322
29. 2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis. J. Immunol. 178, 8138-8147
30. Sheibanie, A.F. et al. (2007) Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/ interleukin-17 axis. Arthritis Rheum. 56, 2608-2619 (Pubitemid 47237279)
31. Libioulle, C. et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58
32. Sawcer, S. et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219
33. Wiebers, D.O. et al. (2002) Unruptured aneurysms. J. Neurosurg. 96, 50-51 (Pubitemid 34229981)
34. van Gijn, J. et al. (2007) Subarachnoid haemorrhage. Lancet 369, 306-318 (Pubitemid 46136491)
35. 2-EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br. J. Pharmacol. 163, 1237-1249
36. Chulada, P.C. et al. (2000) Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 60, 4705-4708
37. Δ716knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809
38. Janne, P.A. and Mayer, R.J. (2000) Chemoprevention of colorectal cancer. N. Engl. J. Med. 342, 1960-1968 (Pubitemid 30419092)
39. Rothwell, P.M. et al. (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376, 1741-1750
40. Sonoshita, M. et al. (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice. Nat. Med. 7, 1048-1051 (Pubitemid 32937386)
41. Shin, V.Y. et al. (2011) NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 32, 240-245
42. Catassi, A. et al. (2008) Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat. Res. 659, 221-231
43. Erez, N. et al. (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell 17, 135-147
44. Benoit, V. et al. (2006) Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappa B. Oncogene 25, 5708-5718 (Pubitemid 44435248)
45. St-Germain, M.E. et al. (2004) Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB/IkB pathway. Mol. Cancer 3, 7
46. Neufert, C. et al. (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc. 2, 1998-2004 (Pubitemid 47308138)
47. Aoki, T. et al. (2009) Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 40, 942-951
48. Aoki, T. et al. (2007) Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 38, 162-169 (Pubitemid 46035622)
49. Kanematsu, Y. et al. (2011) Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 42, 173-178
50. Katoh, H. et al. (2010) COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems. Am. J. Pathol. 176, 1469-1483
51. 2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203, 941-951
52. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seventransmembrane receptor CRTH2. J. Exp. Med. 193, 255-261
53. 2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. J. Immunol. 180, 541-549
54. 2 as a mediator of allergic asthma. Science 287, 2013-2017
55. Kunikata, T. et al. (2005) Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat. Immunol. 6, 524-531 (Pubitemid 41716766)
56. 2 on the proliferation of colon cancer cells. J Pharmacol. Exp. Ther. 336, 516-523
57. 2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. J. Biol. Chem. 279, 46700-46705
58. 2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J. Exp. Med. 197, 221-232
59. Kamata, H. et al. (2010) mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice. Biomed. Pharmacother. 64, 409-416
60. 2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-b. Nat. Med. 15, 1426-1430
61. Lovgren, A.K. et al. (2006) COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L144-L156 (Pubitemid 44148098)
62. Francois, H. et al. (2005) Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab. 2, 201-207
63. Wang, D. et al. (2009) Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm, function. Proc. Natl. Acad. Sci. U.S.A. 106, 7548-7552
64. Eruslanov, E. et al. (2010) Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE catabolism in myeloid cells. J. Leukoc. Biol. 88, 839-848
65. 2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 67, 4507-4513
66. + T regulatory cell activities in lung cancer. Cancer Res. 65, 5211-5220
67. 2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc. Natl. Acad. Sci. U.S.A. 108, 6668-6673
68. Levy, B.D. (2010) Resolvins and protectins: natural pharmacophores for resolution biology. Prostaglandins Leukot. Essent. Fatty Acids 82, 327-332